Blossom Microbiotics

Blossom Microbiotics is a clinical-stage biotechnology company focused on the development of microbiome-based therapeutics for women's health. The company's primary mission is to restore and maintain a healthy vaginal microbiome through the use of specific, high-purity Lactobacillus strains. Their lead product candidate, BL-11, is a live biotherapeutic product (LBP) containing Lactobacillus crispatus designed to treat bacterial vaginosis and prevent its recurrence. Beyond infectious disease, Blossom is exploring the role of the vaginal ecosystem in preventing preterm birth and reducing the incidence of urinary tract infections. The company leverages proprietary stabilization and delivery technologies to ensure the viability and colonization of their microbial strains. Founded by industry veterans, Blossom aims to address significant unmet needs in gynecological and obstetric health.